Abstract
Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies.
Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.Keywords: Cardiovascular diseases, genomics, metabolomics, innovation and communication technology, personalized medicine.
Current Pharmacogenomics and Personalized Medicine
Title:Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Volume: 15 Issue: 1
Author(s): Rosa Finelli, Antonietta V. Pascale, Paola Marotta, Anna Guida and Michele Ciccarelli*
Affiliation:
- Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi (Salerno),Italy
Keywords: Cardiovascular diseases, genomics, metabolomics, innovation and communication technology, personalized medicine.
Abstract: Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies.
Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.Export Options
About this article
Cite this article as:
Finelli Rosa, Pascale V. Antonietta , Marotta Paola, Guida Anna and Ciccarelli Michele*, Tackling Cardiovascular Risk: New Evidence from Personalized Medicine, Current Pharmacogenomics and Personalized Medicine 2017; 15 (1) . https://dx.doi.org/10.2174/1875692115666170508152128
DOI https://dx.doi.org/10.2174/1875692115666170508152128 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn
Current Respiratory Medicine Reviews Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy
Anti-Cancer Agents in Medicinal Chemistry Recent Patents in Cartilage Regeneration
Recent Patents on Regenerative Medicine NAP and ADNF-9 Protect Normal and Downs Syndrome Cortical Neurons from Oxidative Damage and Apoptosis
Current Pharmaceutical Design Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain
Current Pharmaceutical Design Cellular and Network Mechanisms Underlying Memory Impairment Induced by Amyloid β Protein
Protein & Peptide Letters Lipids and Lysosomes
Current Drug Metabolism Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile
Current Drug Safety Nutraceuticals and Bio-inspired Materials from Microalgae and their Future Perspectives
Current Topics in Medicinal Chemistry Trophoblast Invasion: A Possible Link Between Implantation Deficiencies and Preeclampsia
Current Women`s Health Reviews Receptor-Based Design of Cytokine Therapeutics
Current Pharmaceutical Biotechnology A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
CNS & Neurological Disorders - Drug Targets Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design The Impact of Methodology and Confounding Variables on the Association Between Major Depression and Coronary Heart Disease: Review and Recommendations
Current Psychiatry Reviews Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy
Current Drug Targets The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function
Endocrine, Metabolic & Immune Disorders - Drug Targets The Molecular Pathology of Huntingtons Disease (HD)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Toxin-Labeled Monoclonal Antibodies
Current Pharmaceutical Biotechnology Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Dynamics Simulations of Kv Channels and Gating-Modifier Peptide Toxins
Current Computer-Aided Drug Design